ALLEVIATE-1: A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty (clinicaltrials.gov) - Dec 13, 2024 - P3 | N=300 | Active, not recruiting | Sponsor: Tris Pharma, Inc. | Not yet recruiting ➔ Active, not recruiting | Trial primary completion date: Apr 2025 ➔ Dec 2024
Enrollment closed • Trial primary completion date • Aesthetic Medicine • Pain
|